SLRN Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $23,698,008.00
Insider Selling (Last 12 Months): $0.00

Acelyrin Insider Trading History Chart

This chart shows the insider buying and selling history at Acelyrin by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Acelyrin Share Price & Price History

Current Price: $17.50
Price Change: Price Decrease of -0.35 (-1.96%)
As of 06/2/2023 01:00 AM ET

This chart shows the closing price history over time for SLRN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Acelyrin Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/9/2023Beth C SeidenbergDirectorBuy60,000$18.00$1,080,000.0060,000View SEC Filing Icon  
5/9/2023Biopartners Fund Ii WestlakeMajor ShareholderBuy1,250,000$18.00$22,500,000.009,790,729View SEC Filing Icon  
5/9/2023Mardi DierCFOBuy5,556$18.00$100,008.005,556View SEC Filing Icon  
5/9/2023Ronald OystonInsiderBuy1,000$18.00$18,000.001,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Acelyrin (NASDAQ:SLRN)

Acelyrin logo
Acelyrin Inc. is a clinical biopharma company. It focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep. Acelyrin Inc. is based in Agoura Hills, California.
Read More on Acelyrin

Today's Range

Now: $17.50
Low: $16.84
High: $18.22

50 Day Range


52 Week Range

Now: $17.50
Low: $16.84
High: $25.84


428,542 shs

Average Volume

1,069,018 shs

Market Capitalization

$1.62 billion

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Acelyrin?

Acelyrin's top insider investors include:
  1. Biopartners Fund Ii Westlake (Major Shareholder)
  2. Beth C Seidenberg (Director)
  3. Mardi Dier (CFO)
  4. Ronald Oyston (Insider)
Learn More about top insider investors at Acelyrin.
The Ultimate Passive Income Play
The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas. 

Find Out What It Is Right Here.